Annual Current Liabilities
N/A
December 1, 2024
Summary
- ABT annual total current liabilities is not available.
Performance
ABT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
N/A
December 1, 2024
Summary
- ABT quarterly total current liabilities is not available.
Performance
ABT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ABT Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
ABT Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
Abbott Laboratories Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $14.90 B(+8.3%) |
Jun 2024 | - | $13.76 B(-1.9%) |
Mar 2024 | - | $14.02 B(+1.3%) |
Dec 2023 | $13.84 B(-10.6%) | $13.84 B(+6.1%) |
Sep 2023 | - | $13.04 B(-9.1%) |
Jun 2023 | - | $14.35 B(-1.2%) |
Mar 2023 | - | $14.53 B(-6.2%) |
Dec 2022 | $15.49 B(+18.2%) | $15.49 B(+15.9%) |
Sep 2022 | - | $13.37 B(+7.9%) |
Jun 2022 | - | $12.39 B(-2.0%) |
Mar 2022 | - | $12.65 B(-3.5%) |
Dec 2021 | $13.11 B(+10.1%) | $13.11 B(+1.8%) |
Sep 2021 | - | $12.87 B(+2.0%) |
Jun 2021 | - | $12.61 B(+1.2%) |
Mar 2021 | - | $12.46 B(+4.7%) |
Dec 2020 | $11.91 B(+9.6%) | $11.91 B(+16.1%) |
Sep 2020 | - | $10.26 B(-6.4%) |
Jun 2020 | - | $10.96 B(+1.4%) |
Mar 2020 | - | $10.81 B(-0.5%) |
Dec 2019 | $10.86 B(+20.5%) | $10.86 B(+3.5%) |
Sep 2019 | - | $10.49 B(+15.8%) |
Jun 2019 | - | $9.06 B(-0.6%) |
Mar 2019 | - | $9.11 B(+1.1%) |
Dec 2018 | $9.01 B(+1.1%) | $9.01 B(-29.5%) |
Sep 2018 | - | $12.78 B(+42.7%) |
Jun 2018 | - | $8.95 B(-0.7%) |
Mar 2018 | - | $9.01 B(+1.1%) |
Dec 2017 | $8.91 B(+33.8%) | $8.91 B(+12.3%) |
Sep 2017 | - | $7.93 B(+16.6%) |
Jun 2017 | - | $6.80 B(+2.4%) |
Mar 2017 | - | $6.65 B(-0.2%) |
Dec 2016 | $6.66 B(-27.5%) | $6.66 B(-20.0%) |
Sep 2016 | - | $8.32 B(-4.1%) |
Jun 2016 | - | $8.67 B(+3.3%) |
Mar 2016 | - | $8.39 B(-8.6%) |
Dec 2015 | $9.19 B(-12.2%) | $9.19 B(+4.9%) |
Sep 2015 | - | $8.76 B(-4.7%) |
Jun 2015 | - | $9.19 B(-0.2%) |
Mar 2015 | - | $9.21 B(-12.0%) |
Dec 2014 | $10.47 B(+10.1%) | $10.47 B(-3.3%) |
Sep 2014 | - | $10.82 B(+9.8%) |
Jun 2014 | - | $9.85 B(-3.3%) |
Mar 2014 | - | $10.19 B(+7.1%) |
Dec 2013 | $9.51 B(-28.4%) | $9.51 B(-16.1%) |
Sep 2013 | - | $11.33 B(+3.8%) |
Jun 2013 | - | $10.92 B(+4.9%) |
Mar 2013 | - | $10.41 B(-21.6%) |
Dec 2012 | $13.28 B(-14.2%) | $13.28 B(-18.5%) |
Sep 2012 | - | $16.29 B(-4.9%) |
Jun 2012 | - | $17.12 B(+2.0%) |
Mar 2012 | - | $16.79 B(+8.4%) |
Dec 2011 | $15.48 B(-10.3%) | $15.48 B(+0.4%) |
Sep 2011 | - | $15.41 B(-2.7%) |
Jun 2011 | - | $15.84 B(-8.0%) |
Mar 2011 | - | $17.23 B(-0.2%) |
Dec 2010 | $17.26 B(+32.3%) | $17.26 B(+10.8%) |
Sep 2010 | - | $15.58 B(+6.1%) |
Jun 2010 | - | $14.69 B(-3.3%) |
Mar 2010 | - | $15.18 B(+16.4%) |
Dec 2009 | $13.05 B(+12.6%) | $13.05 B(+4.2%) |
Sep 2009 | - | $12.52 B(+4.0%) |
Jun 2009 | - | $12.04 B(+2.3%) |
Mar 2009 | - | $11.77 B(+1.5%) |
Dec 2008 | $11.59 B(+27.3%) | $11.59 B(+21.3%) |
Sep 2008 | - | $9.56 B(-20.4%) |
Jun 2008 | - | $12.02 B(+11.6%) |
Mar 2008 | - | $10.77 B(+18.3%) |
Dec 2007 | $9.10 B(-23.8%) | $9.10 B(-25.9%) |
Sep 2007 | - | $12.28 B(+2.3%) |
Jun 2007 | - | $12.01 B(-2.4%) |
Mar 2007 | - | $12.31 B(+3.0%) |
Dec 2006 | $11.95 B | $11.95 B(+60.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2006 | - | $7.43 B(-3.4%) |
Jun 2006 | - | $7.69 B(+7.5%) |
Mar 2006 | - | $7.16 B(-3.4%) |
Dec 2005 | $7.42 B(+8.6%) | $7.42 B(-15.3%) |
Sep 2005 | - | $8.76 B(+44.0%) |
Jun 2005 | - | $6.08 B(-17.4%) |
Mar 2005 | - | $7.37 B(+7.9%) |
Dec 2004 | $6.83 B(-2.0%) | $6.83 B(-6.4%) |
Sep 2004 | - | $7.30 B(-4.3%) |
Jun 2004 | - | $7.62 B(+9.6%) |
Mar 2004 | - | $6.95 B(-0.1%) |
Dec 2003 | $6.96 B(-0.6%) | $6.96 B(-13.4%) |
Sep 2003 | - | $8.04 B(+9.6%) |
Jun 2003 | - | $7.33 B(+5.6%) |
Mar 2003 | - | $6.94 B(-0.8%) |
Dec 2002 | $7.00 B(-11.7%) | $7.00 B(+4.2%) |
Sep 2002 | - | $6.72 B(-2.2%) |
Jun 2002 | - | $6.87 B(-1.2%) |
Mar 2002 | - | $6.95 B(-12.3%) |
Dec 2001 | $7.93 B(+84.5%) | $7.93 B(+1.9%) |
Sep 2001 | - | $7.78 B(+5.0%) |
Jun 2001 | - | $7.41 B(-32.0%) |
Mar 2001 | - | $10.89 B(+153.4%) |
Dec 2000 | $4.30 B(-4.9%) | $4.30 B(+0.3%) |
Sep 2000 | - | $4.28 B(+2.3%) |
Jun 2000 | - | $4.19 B(-6.9%) |
Mar 2000 | - | $4.50 B(-0.4%) |
Dec 1999 | $4.52 B(-9.0%) | $4.52 B(+4.3%) |
Sep 1999 | - | $4.33 B(+3.8%) |
Jun 1999 | - | $4.17 B(-11.4%) |
Mar 1999 | - | $4.71 B(-5.2%) |
Dec 1998 | $4.97 B(-1.4%) | $4.97 B(+6.5%) |
Sep 1998 | - | $4.66 B(-6.7%) |
Jun 1998 | - | $5.00 B(+5.8%) |
Mar 1998 | - | $4.73 B(-6.1%) |
Dec 1997 | $5.03 B(+15.9%) | $5.03 B(+6.6%) |
Sep 1997 | - | $4.72 B(+4.6%) |
Jun 1997 | - | $4.51 B(+3.1%) |
Mar 1997 | - | $4.38 B(+0.8%) |
Dec 1996 | $4.34 B(+14.6%) | $4.34 B(+1.3%) |
Sep 1996 | - | $4.29 B(-5.3%) |
Jun 1996 | - | $4.53 B(+29.7%) |
Mar 1996 | - | $3.49 B(-7.9%) |
Dec 1995 | $3.79 B(+9.0%) | $3.79 B(+6.3%) |
Sep 1995 | - | $3.57 B(+0.9%) |
Jun 1995 | - | $3.54 B(-1.5%) |
Mar 1995 | - | $3.59 B(+3.3%) |
Dec 1994 | $3.48 B(+12.3%) | $3.48 B(+2.0%) |
Sep 1994 | - | $3.41 B(+4.2%) |
Jun 1994 | - | $3.27 B(+7.0%) |
Mar 1994 | - | $3.05 B(-1.3%) |
Dec 1993 | $3.09 B(+11.2%) | $3.09 B(-0.7%) |
Sep 1993 | - | $3.12 B(+1.7%) |
Jun 1993 | - | $3.06 B(+2.1%) |
Mar 1993 | - | $3.00 B(+7.9%) |
Dec 1992 | $2.78 B(+24.8%) | $2.78 B(+3.7%) |
Sep 1992 | - | $2.68 B(+15.8%) |
Jun 1992 | - | $2.32 B(+2.8%) |
Mar 1992 | - | $2.25 B(+1.1%) |
Dec 1991 | $2.23 B(+11.4%) | $2.23 B(+8.0%) |
Sep 1991 | - | $2.06 B(-0.3%) |
Jun 1991 | - | $2.07 B(+1.4%) |
Mar 1991 | - | $2.04 B(+2.0%) |
Dec 1990 | $2.00 B(+44.6%) | $2.00 B(-8.3%) |
Sep 1990 | - | $2.18 B(+15.0%) |
Jun 1990 | - | $1.90 B(+14.5%) |
Mar 1990 | - | $1.66 B(+19.7%) |
Dec 1989 | $1.38 B(-3.9%) | $1.38 B(-3.9%) |
Dec 1988 | $1.44 B(-3.2%) | $1.44 B(-3.2%) |
Dec 1987 | $1.49 B(+14.1%) | $1.49 B(+14.1%) |
Dec 1986 | $1.30 B(+65.3%) | $1.30 B(+65.3%) |
Dec 1985 | $788.50 M(-2.2%) | $788.50 M(-2.2%) |
Dec 1984 | $806.40 M | $806.40 M |
FAQ
- What is the all time high annual current liabilities for Abbott Laboratories?
- What is the all time high quarterly current liabilities for Abbott Laboratories?
What is the all time high annual current liabilities for Abbott Laboratories?
Abbott Laboratories all-time high annual total current liabilities is $17.26 B
What is the all time high quarterly current liabilities for Abbott Laboratories?
Abbott Laboratories all-time high quarterly total current liabilities is $17.26 B